Biogen (BIIB) Inventory (2009 - 2026)

Biogen has reported Inventory for 18 years, with the latest figure at $2.4 billion in Q2 2026.

• On a quarterly basis, Inventory rose 4.84% year-over-year to $2.4 billion in Q2 2026; TTM through Jun 2026 was $2.4 billion, a 4.84% increase from a year earlier, with the FY2025 full-year figure at $2.2 billion, down 11.88% from the prior year.
• Inventory was $2.4 billion for Q2 2026 at Biogen, up from $1.9 billion in the prior quarter.
• The five-year high for Inventory was $3.0 billion in Q3 2023, with the low at $1.2 billion in Q1 2022.
• Average Inventory over 5 years is $2.0 billion, with a median of $2.2 billion recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Inventory soared 116.9% in 2023, then dropped 17.21% in 2024.
• Over 5 years, Inventory stood at $1.3 billion in 2022, then jumped by 87.99% to $2.5 billion in 2023, then fell by 2.65% to $2.5 billion in 2024, then retreated by 11.88% to $2.2 billion in 2025, then climbed by 9.97% to $2.4 billion in 2026.
• The last three Inventory figures came in at $2.4 billion (Q2 2026), $1.9 billion (Q1 2026), and $2.2 billion (Q4 2025), per Business Quant data.